Get App Open
In App
Credit Cards
Open App

Supriya Lifescience Ltd.

BSE: 543434 | NSE: SUPRIYA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE07RO01027 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Nov 27, 16:01
763.30 -4.10 (-0.53%)
Volume
AVERAGE VOLUME
5-Day
28,672
10-Day
42,737
30-Day
80,862
10,391
  • Prev. Close

    767.40

  • Open Price

    774.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Nov 27, 15:52
761.75 -5.80 (-0.76%)
Volume
AVERAGE VOLUME
5-Day
396,898
10-Day
442,557
30-Day
796,152
117,612
  • Prev. Close

    767.55

  • Open Price

    772.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    761.75 (503)

Financials

Profit & Loss account of Supriya Lifescience (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22  
  12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 765.00 634.03 506.55 530.05  
Less: Excise/Sevice Tax/Other Levies 85.44 76.59 55.53 0.00  
Revenue From Operations [Net] 679.56 557.44 451.01 530.05  
Total Operating Revenues 696.49 570.37 460.94 530.05  
Other Income 9.82 10.64 9.49 7.58  
Total Revenue 706.30 581.01 470.43 537.63  
EXPENSES  
Cost Of Materials Consumed 232.44 191.43 187.32 198.83  
Purchase Of Stock-In Trade 0.00 0.00 0.00 0.00  
Operating And Direct Expenses 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -21.26 30.31 -6.51 -3.03  
Employee Benefit Expenses 80.52 67.64 55.58 49.08  
Finance Costs 1.69 2.11 3.08 4.20  
Depreciation And Amortisation Expenses 20.44 15.81 11.82 10.12  
Other Expenses 143.99 108.02 95.65 71.18  
Total Expenses 457.82 415.32 346.94 330.38  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 248.48 165.69 123.49 207.25  
Exceptional Items 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 248.48 165.69 123.49 207.25  
Tax Expenses-Continued Operations  
Current Tax 56.66 37.10 30.68 52.19  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00  
Deferred Tax 3.87 9.48 2.95 3.25  
Tax For Earlier Years 0.00 0.00 0.00 0.00  
Total Tax Expenses 60.52 46.58 33.63 55.44  
Profit/Loss After Tax And Before ExtraOrdinary Items 187.96 119.11 89.86 151.81  
Profit/Loss From Continuing Operations 187.96 119.11 89.86 151.81  
Profit/Loss For The Period 187.96 119.11 89.86 151.81  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 23.35 14.80 11.16 18.86  
Diluted EPS (Rs.) 23.35 14.80 11.16 18.86  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 6.44 4.83 4.83 4.39  
Tax On Dividend 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 50.00 40.00 30.00 30.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347